These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38439794)

  • 1. Anhedonia and depression severity measures during ketamine administration in treatment-resistant depression.
    Kwaśny A; Cubała WJ; Włodarczyk A
    Front Psychiatry; 2024; 15():1334293. PubMed ID: 38439794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression.
    Wilkowska A; Wiglusz MS; Gałuszko-Wegielnik M; Włodarczyk A; Cubała WJ
    Front Psychiatry; 2021; 12():704330. PubMed ID: 34733182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anhedonia in bipolar depression treated with ketamine.
    Wilkowska A; Wiglusz MS; Arciszewska-Leszczuk A; Gałuszko-Węgielnik M; Cubała WJ
    Bipolar Disord; 2024 Jun; 26(4):356-363. PubMed ID: 38311367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder.
    Zheng W; Gu L; Zhou Y; Wang C; Lan X; Zhang B; Li Z; Ning Y
    Curr Neuropharmacol; 2023; 21(4):1013-1021. PubMed ID: 36173064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anhedonia and suicidal ideation in patients with treatment-refractory depression after intravenous ketamine infusions.
    Zheng W; Gu LM; Yang XH; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP
    Int J Psychiatry Clin Pract; 2023 Jun; 27(2):145-150. PubMed ID: 36309806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence.
    Rodrigues NB; McIntyre RS; Lipsitz O; Cha DS; Lee Y; Gill H; Majeed A; Phan L; Nasri F; Ho R; Lin K; Subramaniapillai M; Kratiuk K; Mansur RB; Rosenblat JD
    J Affect Disord; 2020 Nov; 276():570-575. PubMed ID: 32871688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianhedonic effects of serial intravenous subanaesthetic ketamine in anxious versus nonanxious depression.
    Zheng W; Yang XH; Gu LM; Tan JQ; Zhou YL; Wang CY; Ning YP
    J Affect Disord; 2022 Sep; 313():72-76. PubMed ID: 35772627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression.
    Zheng W; Gu LM; Zhou YL; Wang CY; Lan XF; Zhang B; Shi HS; Wang DF; Ning YP
    Front Psychiatry; 2021; 12():780975. PubMed ID: 34925104
    [No Abstract]   [Full Text] [Related]  

  • 9. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.
    Ballard ED; Wills K; Lally N; Richards EM; Luckenbaugh DA; Walls T; Ameli R; Niciu MJ; Brutsche NE; Park L; Zarate CA
    J Affect Disord; 2017 Aug; 218():195-200. PubMed ID: 28477497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression.
    Zheng W; Yang XH; Gu LM; Tan JQ; Zhou YL; Wang CY; Ning YP
    Front Psychiatry; 2022; 13():981981. PubMed ID: 36186882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression.
    Zheng W; Gu LM; Sun CH; Zhou YL; Wang CY; Lan XF; Zhang B; Ning YP
    J Affect Disord; 2022 Mar; 300():109-113. PubMed ID: 34965393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales.
    Ballard ED; Yarrington JS; Farmer CA; Lener MS; Kadriu B; Lally N; Williams D; Machado-Vieira R; Niciu MJ; Park L; Zarate CA
    J Affect Disord; 2018 Apr; 231():51-57. PubMed ID: 29448238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study.
    Wilkowska A; Włodarczyk A; Gałuszko-Węgielnik M; Wiglusz MS; Cubała WJ
    Neuropsychiatr Dis Treat; 2021; 17():2637-2646. PubMed ID: 34421299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric evaluation of the Snaith-Hamilton pleasure scale in adult outpatients with major depressive disorder.
    Nakonezny PA; Carmody TJ; Morris DW; Kurian BT; Trivedi MH
    Int Clin Psychopharmacol; 2010 Nov; 25(6):328-33. PubMed ID: 20805756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and Validity of the Snaith-Hamilton Pleasure Scale Clinician Administered Turkish Form.
    Gürcan A; Başar K; Şen ZD; Karakaşli AA
    Turk Psikiyatri Derg; 2022; 33(3):187-195. PubMed ID: 36148569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest-activity symptom severity predicts response to ketamine infusion in treatment-resistant depression.
    Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Su TP
    Psychopharmacology (Berl); 2021 Mar; 238(3):857-865. PubMed ID: 33471146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation.
    Rodrigues NB; Siegel A; Lipsitz O; Cha DS; Gill H; Nasri F; Simonson K; Shekotikhina M; Lee Y; Subramaniapillai M; Kratiuk K; Lin K; Ho R; Mansur RB; McIntyre RS; Rosenblat JD
    CNS Spectr; 2022 Jun; 27(3):315-321. PubMed ID: 33298225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
    Lally N; Nugent AC; Luckenbaugh DA; Ameli R; Roiser JP; Zarate CA
    Transl Psychiatry; 2014 Oct; 4(10):e469. PubMed ID: 25313512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper and anti-anhedonic effect of ketamine in treatment-resistant depression.
    Słupski J; Cubała WJ; Górska N; Słupska A; Gałuszko-Węgielnik M
    Med Hypotheses; 2020 Nov; 144():110268. PubMed ID: 33254572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.
    Lally N; Nugent AC; Luckenbaugh DA; Niciu MJ; Roiser JP; Zarate CA
    J Psychopharmacol; 2015 May; 29(5):596-607. PubMed ID: 25691504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.